A study of RXI-762 for the treatment of cancer.
Phase of Trial: Phase I
Latest Information Update: 14 Aug 2017
At a glance
- Drugs RXI-762 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 14 Aug 2017 New trial record
- 08 Aug 2017 According to RXi Pharmaceuticals media release, the company plans clinical development of RXI-762 in 2018.